Latest Breaking News On - Axis is deserving - Page 1 : comparemela.com

According to an analyst at Goldman Smallcap Research, NeurAxis Inc. shares at current levels present a compelling investment opportunity. In fact, he models for a 12-month price target of $14 a.

United statesRob goldmanJack enterprisesHawk point media group llcBoston scientific corpNeuraxis incGoldman smallcap researchSmallcap researchStim is already scoringStim to target post concussionImmediate post concussion assessmentPost concussion symptom scaleBalance error scoring symptomBig pharmaAxis is deservingPoint media group